Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF vs Nippon India Equity Hybrid Fund

A weighted portfolio overlap of 1.46% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹1.46 is allocated to the exact same companies at the same relative proportions. The schemes share 5 common holdings.

The largest overlapping asset in their portfolios is Gland Pharma, which commands a weight of 1.85% in Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF and 0.37% in Nippon India Equity Hybrid Fund. Holding both schemes increases your concentration in Gland Pharma rather than expanding your diversification.

If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).